Ho‐Wan Ip

Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study

Harinder Gill, Rita Yim, Harold K. K. Lee et al. · Cancer · 2018 · 79 citations · Full text

Medicine, Hematology, Oncology +10

Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for<i>FLT3</i><i>-</i>ITD acute myeloid leukemia

Stephen S.Y. Lam, Eric S.K. Ho, Bai‐Liang He et al. · Science Translational Medicine · 2016 · 74 citations

Medicine, Oncology, Pharmacology +16

Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study

Harinder Gill, Cyrus R. Kumana, Rita Yim et al. · Cancer · 2019 · 55 citations · Full text

Medicine, Hematology, Oncology +15

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3

Chunxiao Zhang, Stephen S.Y. Lam, Garret M. K. Leung et al. · Cancer · 2019 · 35 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis

Harinder Gill, Ho‐Wan Ip, Rita Yim et al. · Annals of Hematology · 2018 · 22 citations

Life Sciences, Genetics, Hematology +13